Axsome TherapeuticsNASDAQ: AXSM

One of the critical components of the investing world is the proliferation and understanding of analyst predictions. That's because most retail investors prefer to research consumer information regarding stock picks through the calculations of those deemed more experienced in understanding financial fundamentals.

Axsome Therapeutics was recently the target of an activist short seller. The allegations will impact the biotech's financials if they are true.

A short-seller alleged that Axsome has deals with mail-order pharmacies that inflate its reported revenue. If these allegations are proven true, the company could have to eventually restate its revenue.

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on solriamfetol at SLEEP 2024, the 38th annual meeting of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS), being held June 1-5, 2024, in Houston, Texas. “Cognitive functioning is an underappreciated facet of sleep disorders.

Axsome Therapeutics (AXSM) is experiencing positive changes in earnings estimates and has a favorable Zacks Earnings ESP as earnings season approaches.

Investing in biotech stocks allows for the possibility of significant financial returns while also supporting the development of life-saving treatments and medications.

Axsome (AXSM) lacks the necessary elements for a potential earnings surprise in its upcoming report. Be ready with the important expectations.

Axsome's (AXSM) phase III ENGAGE study is set to evaluate the efficacy and safety of solriamfetol for the treatment of binge eating disorder in adults.

Biotech has seen its fair share of ups and downs, including a massive surge during the pandemic followed by a considerable dip. However, the industry will never go too far away from center stage as diseases and conditions will always need medicine and technology to treat them.